Boehringer Ingelheim partners with NCD Alliance to target Non-Communicable Diseases in underserved communities Read more
Phare Bio Secures Up to $27 Million from ARPA-H to Propel AI-Driven Drug Discovery and Innovate New Antibiotics Read more
Tempus Expands Partnership with Takeda to Enhance Oncology Research Using Multimodal Real-World Data and Biological Models Read more
Tagrisso approved in the US for patients with unresectable, Stage III EGFR-mutated lung cancer Read more
Pfizer Voluntarily Withdraws All Lots of Sickle Cell Disease Treatment OXBRYTA (voxelotor) From Worldwide Markets Read more
Lilly’s Kisunla (donanemab-azbt) Approved in Japan for the Treatment of Early Symptomatic Alzheimer’s Disease Read more
Papillon Therapeutics Secures Orphan Drug Designation from FDA for PPL-001 in Friedreich’s Ataxia Treatment Read more